Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lohmann

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Oncogene|July 12, 2005
Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastomaCorinna Grasemann, Sandrine Gratias, Harald Stephan, et al.
Experimental Eye Research|May 10, 2014
Genetic testing in Tunisian families with heritable retinoblastoma using a low cost approach permits accurate risk prediction in relatives and reveals incomplete penetrance in adultsHajer Ayari Jeridi, Hédi Bouguila, Birgit Ansperger-Rescher, et al.
Transplantation Proceedings|June 24, 1998
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantationJ M Langrehr, A Schneller, O Guckelberger, et al.
Zeitschrift Fur Arztliche Fortbildung|April 1, 1994
[Living with a liver transplant--indications, prognosis and quality of life]J M Langrehr, H Keck, W O Bechstein, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|March 27, 2001
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantationJ M Langrehr, R Lohmann, O Guckelberger, et al.
American Journal of Medical Genetics. Part A|April 1, 2009
Microcephaly, microtia, preauricular tags, choanal atresia and developmental delay in three unrelated patients: a mandibulofacial dysostosis distinct from Treacher Collins syndromeDagmar Wieczorek, Blanca Gener, Ma Jesús Martínez González, et al.
Cancer Research|April 20, 2001
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanomaF Tschentscher, G Prescher, D E Horsman, et al.
Nature Genetics|June 25, 2013
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3Marcel Martin, Lars Maßhöfer, Petra Temming, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Oncogene|July 12, 2005
Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastomaCorinna Grasemann, Sandrine Gratias, Harald Stephan, et al.
Experimental Eye Research|May 10, 2014
Genetic testing in Tunisian families with heritable retinoblastoma using a low cost approach permits accurate risk prediction in relatives and reveals incomplete penetrance in adultsHajer Ayari Jeridi, Hédi Bouguila, Birgit Ansperger-Rescher, et al.
Transplantation Proceedings|June 24, 1998
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantationJ M Langrehr, A Schneller, O Guckelberger, et al.
Zeitschrift Fur Arztliche Fortbildung|April 1, 1994
[Living with a liver transplant--indications, prognosis and quality of life]J M Langrehr, H Keck, W O Bechstein, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|March 27, 2001
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantationJ M Langrehr, R Lohmann, O Guckelberger, et al.
American Journal of Medical Genetics. Part A|April 1, 2009
Microcephaly, microtia, preauricular tags, choanal atresia and developmental delay in three unrelated patients: a mandibulofacial dysostosis distinct from Treacher Collins syndromeDagmar Wieczorek, Blanca Gener, Ma Jesús Martínez González, et al.
Cancer Research|April 20, 2001
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanomaF Tschentscher, G Prescher, D E Horsman, et al.
Nature Genetics|June 25, 2013
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3Marcel Martin, Lars Maßhöfer, Petra Temming, et al.
Pageof 17